Filing Details

Accession Number:
0001415889-22-002578
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 18:17:25
Reporting Period:
2022-03-02
Accepted Time:
2022-03-04 18:17:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1830122 Daniel Trencher C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Svp Corporate Strategy No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-02 1,004 $0.00 24,490 No 4 M Direct
Common Stock Acquisiton 2022-03-02 1,708 $0.00 26,198 No 4 M Direct
Common Stock Acquisiton 2022-03-02 429 $0.00 26,627 No 4 M Direct
Common Stock Acquisiton 2022-03-02 956 $0.00 27,583 No 4 M Direct
Common Stock Acquisiton 2022-03-02 723 $0.00 28,306 No 4 M Direct
Common Stock Disposition 2022-03-03 1,797 $70.24 26,509 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-03-02 1,004 $0.00 1,004 $0.00
Common Stock Performance Stock Units Disposition 2022-03-02 1,708 $0.00 1,708 $0.00
Common Stock Performance Stock Units Acquisiton 2022-03-02 859 $0.00 859 $0.00
Common Stock Performance Stock Units Disposition 2022-03-02 429 $0.00 429 $0.00
Common Stock Restricted Stock Units Disposition 2022-03-02 956 $0.00 956 $0.00
Common Stock Performance Stock Units Acquisiton 2022-03-02 2,168 $0.00 2,168 $0.00
Common Stock Performance Stock Units Disposition 2022-03-02 723 $0.00 723 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,004 No 4 M Direct
1,706 No 4 M Direct
859 No 4 A Direct
430 No 4 M Direct
1,912 No 4 M Direct
2,168 No 4 A Direct
1,445 No 4 M Direct
Footnotes
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
  4. On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  5. On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
  6. Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  7. Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021.
  8. The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022.
  9. On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
  10. On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  11. Performance award amount determined based on metrics in respect of the issuer's 2021 financial results
  12. The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022.
  13. On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.